Zivo Bioscience, Inc. Balance Sheet
ZIVO|14 years of annual SEC 10-K data (FY2010-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 14 fiscal years. All figures from audited SEC 10-K filings.
Zivo Bioscience, Inc. had $2M in total assets with negative shareholders' equity of $514,897 as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -96.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | $1.8M | $8.9M | $137.9K | $346.1K | $388.9K | $507.0K | $16.6K | $1.4K | $493.1K | $47.1K | $225.7K | $15.6K |
| Accounts Receivable | $2.2K | $3.7K | $0 | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | $0 | - |
| Current Assets | $1.6M | $425.4K | $1.9M | $9.0M | $167.8K | $369.4K | $411.5K | $520.4K | $28.9K | $33.1K | $688.5K | $90.8K | $249.8K | - |
| PP&E (Net) | - | $0 | $0 | $0 | $0 | $0 | $0 | $18.8K | $43.8K | $68.8K | $93.8K | $13.2K | $83.5K | - |
| Total Assets | $1.6M | $555.7K | $2.1M | $9.0M | $220.2K | $369.4K | $411.5K | $737.3K | $72.7K | $101.9K | $2.2M | $234.0K | $463.5K | - |
| Current Liabilities | $2.0M | $2.8M | $2.0M | $2.9M | $11.4M | $8.7M | $22.7M | $11.2M | $5.0M | $6.2M | $10.9M | $3.4M | $1.8M | - |
| Shareholders' Equity | -$514.9K | -$2.2M | -$10.6K | $6.0M | -$11.3M | -$8.3M | -$22.3M | -$13.6M | -$9.5M | -$6.4M | -$9.6M | -$4.0M | -$2.0M | - |